Cargando…
Probabilistic drug connectivity mapping
BACKGROUND: The aim of connectivity mapping is to match drugs using drug-treatment gene expression profiles from multiple cell lines. This can be viewed as an information retrieval task, with the goal of finding the most relevant profiles for a given query drug. We infer the relevance for retrieval...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011783/ https://www.ncbi.nlm.nih.gov/pubmed/24742351 http://dx.doi.org/10.1186/1471-2105-15-113 |
_version_ | 1782314844355035136 |
---|---|
author | Parkkinen, Juuso A Kaski, Samuel |
author_facet | Parkkinen, Juuso A Kaski, Samuel |
author_sort | Parkkinen, Juuso A |
collection | PubMed |
description | BACKGROUND: The aim of connectivity mapping is to match drugs using drug-treatment gene expression profiles from multiple cell lines. This can be viewed as an information retrieval task, with the goal of finding the most relevant profiles for a given query drug. We infer the relevance for retrieval by data-driven probabilistic modeling of the drug responses, resulting in probabilistic connectivity mapping, and further consider the available cell lines as different data sources. We use a special type of probabilistic model to separate what is shared and specific between the sources, in contrast to earlier connectivity mapping methods that have intentionally aggregated all available data, neglecting information about the differences between the cell lines. RESULTS: We show that the probabilistic multi-source connectivity mapping method is superior to alternatives in finding functionally and chemically similar drugs from the Connectivity Map data set. We also demonstrate that an extension of the method is capable of retrieving combinations of drugs that match different relevant parts of the query drug response profile. CONCLUSIONS: The probabilistic modeling-based connectivity mapping method provides a promising alternative to earlier methods. Principled integration of data from different cell lines helps to identify relevant responses for specific drug repositioning applications. |
format | Online Article Text |
id | pubmed-4011783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40117832014-05-20 Probabilistic drug connectivity mapping Parkkinen, Juuso A Kaski, Samuel BMC Bioinformatics Methodology Article BACKGROUND: The aim of connectivity mapping is to match drugs using drug-treatment gene expression profiles from multiple cell lines. This can be viewed as an information retrieval task, with the goal of finding the most relevant profiles for a given query drug. We infer the relevance for retrieval by data-driven probabilistic modeling of the drug responses, resulting in probabilistic connectivity mapping, and further consider the available cell lines as different data sources. We use a special type of probabilistic model to separate what is shared and specific between the sources, in contrast to earlier connectivity mapping methods that have intentionally aggregated all available data, neglecting information about the differences between the cell lines. RESULTS: We show that the probabilistic multi-source connectivity mapping method is superior to alternatives in finding functionally and chemically similar drugs from the Connectivity Map data set. We also demonstrate that an extension of the method is capable of retrieving combinations of drugs that match different relevant parts of the query drug response profile. CONCLUSIONS: The probabilistic modeling-based connectivity mapping method provides a promising alternative to earlier methods. Principled integration of data from different cell lines helps to identify relevant responses for specific drug repositioning applications. BioMed Central 2014-04-17 /pmc/articles/PMC4011783/ /pubmed/24742351 http://dx.doi.org/10.1186/1471-2105-15-113 Text en Copyright © 2014 Parkkinen and Kaski; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Article Parkkinen, Juuso A Kaski, Samuel Probabilistic drug connectivity mapping |
title | Probabilistic drug connectivity mapping |
title_full | Probabilistic drug connectivity mapping |
title_fullStr | Probabilistic drug connectivity mapping |
title_full_unstemmed | Probabilistic drug connectivity mapping |
title_short | Probabilistic drug connectivity mapping |
title_sort | probabilistic drug connectivity mapping |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011783/ https://www.ncbi.nlm.nih.gov/pubmed/24742351 http://dx.doi.org/10.1186/1471-2105-15-113 |
work_keys_str_mv | AT parkkinenjuusoa probabilisticdrugconnectivitymapping AT kaskisamuel probabilisticdrugconnectivitymapping |